Larson Mary Jo, Miller Kay, Fleming Kathleen J, Teich Judith L
New England Research Institutes, Watertown, MA 02472, USA.
J Behav Health Serv Res. 2007 Jan;34(1):56-72. doi: 10.1007/s11414-006-9028-0.
This study examines 1999 data from Medstat's MarketScan database of privately insured employees of US firms and their dependents. Of enrolled children and adolescents ages 2-18, 6.6% had claims for mental health services. Average outpatient expenditures per user were $651. Of children/adolescents with claims for mental health services (MH claimants), 3.4% had inpatient MH services, with an average length of stay of 8.9 days and average MH-related inpatient expenditure per user of $7,048. One half of MH claimants who had pharmacy benefit data had claims for psychotropic medications, with average expenditures per user of $328. Whereas children/adolescent mental health users comprised 8.3% of all service users, expenditures for their care were 20.5% of all service expenditures for children/adolescents in private health plans. Results also highlight the importance of including data on psychotropic medication in analysis of children's MH services utilization, as well as the need to consider the use of psychotropic medications among children/adolescents who do not utilize other MH services.
本研究分析了Medstat公司MarketScan数据库中1999年美国企业参保员工及其家属的数据。在年龄为2至18岁的参保儿童和青少年中,6.6%有心理健康服务索赔记录。每位用户的门诊平均支出为651美元。在有心理健康服务索赔记录的儿童/青少年(心理健康索赔者)中,3.4%有心理健康住院服务,平均住院时长为8.9天,每位用户与心理健康相关的住院平均支出为7048美元。在有药房福利数据的心理健康索赔者中,一半有精神类药物索赔记录,每位用户的平均支出为328美元。虽然儿童/青少年心理健康服务使用者占所有服务使用者的8.3%,但他们的护理支出占私人健康保险计划中儿童/青少年所有服务支出的20.5%。研究结果还凸显了在分析儿童心理健康服务利用情况时纳入精神类药物数据的重要性,以及考虑未使用其他心理健康服务的儿童/青少年使用精神类药物情况的必要性。